{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:38:17Z","timestamp":1761061097489,"version":"3.41.2"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00747","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T07:50:55Z","timestamp":1595317855000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Detoxification Improves Multidomain Cognitive Dysfunction in High-Dose Benzodiazepine Abusers"],"prefix":"10.3389","volume":"14","author":[{"given":"Angela","family":"Federico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Lugoboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Morbioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Casari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Faccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"journal-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jhep.2008.04.022","article-title":"Detection of minimal hepatic encephalopathy: normalization and optimization of the psychometric hepatic encephalopathy score. a neuropsychological and quantified EEG study.","volume":"49","author":"Amodio","year":"2008","journal-title":"J. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00213-008-1357-7","article-title":"RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.","volume":"202","author":"Ballard","year":"2009","journal-title":"Psychopharmacology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis.","volume":"18","author":"Barker","year":"","journal-title":"CNS Drugs"},{"key":"B5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis.","volume":"19","author":"Barker","year":"","journal-title":"Arch. Clin. Neuropsychol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study.","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00228-011-1047-y","article-title":"Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort.","volume":"67","author":"Boeuf-Cazou","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10072-015-2428-2","article-title":"An updated Italian normative dataset for the Stroop color word test (SCWT).","volume":"37","author":"Brugnolo","year":"2016","journal-title":"Neurol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s100720200003","article-title":"Rey-Osterrieth complex figure: normative values in an Italian population sample.","volume":"22","author":"Caffarra","year":"2002","journal-title":"Neurol. Sci."},{"key":"B10","first-page":"1","article-title":"Normative data of two memory tasks: short-story recall and Rey\u2019s Figure.","volume":"12","author":"Carlesimo","year":"2002","journal-title":"Nuova Riv. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1159\/000117297","article-title":"The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the mental deterioration battery.","volume":"36","author":"Carlesimo","year":"1996","journal-title":"Eur. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/jnp.12019","article-title":"Modified taylor complex figure: normative data from 290 adults.","volume":"8","author":"Casarotti","year":"2014","journal-title":"J. Neuropsychol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00702-019-01996-z","article-title":"Olfaction and taste in Parkinson\u2019s disease: the association with mild cognitive impairment and the single cognitive domain dysfunction.","volume":"126","author":"Cecchini","year":"2019","journal-title":"J. Neural Trans."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2147\/NDT.S164307","article-title":"Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects.","volume":"14","author":"Cheng","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jagp.2016.04.013","article-title":"Benzodiazepine use attenuates cortical \u03b2-amyloid and is not associated with progressive cognitive decline in nondemented elderly adults: a pilot study using f18-florbetapir positron emission tomography.","volume":"24","author":"Chung","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nlm.2017.02.006","article-title":"Short-term treatment with flumazenil restores long-term object memory in a mouse model of down syndrome.","volume":"140","author":"Colas","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: a nested case-control study.","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal \u03b15 GABAA receptors.","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/sj.bjp.0703717","article-title":"Mechanism of action of the hypnotic zolpidem in vivo.","volume":"131","author":"Crestani","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/arclin\/acx120","article-title":"The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis.","volume":"33","author":"Crowe","year":"2018","journal-title":"Arch. Clin. Neuropsychol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00702-011-0663-0","article-title":"Alzheimer disease: are we intervening too late?","volume":"118","author":"Emery","year":"2011","journal-title":"Proc. J. Neural Transm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1177\/0269881116647505","article-title":"Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases.","volume":"30","author":"Faccini","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10072-016-2732-5","article-title":"Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study.","volume":"38","author":"Federico","year":"2017","journal-title":"Neurol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/j.1532-5415.2011.03591.x","article-title":"Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults.","volume":"59","author":"Finkle","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00406-017-0787-9","article-title":"Benzodiazepine long-term administration is associated with impaired attention\/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.","volume":"268","author":"Fond","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00702-004-0169-0","article-title":"Nicotinic receptors and cognition in Parkinson\u2019s Disease: the importance of neuronal synchrony.","volume":"111","author":"Forgacs","year":"2004","journal-title":"J. Neural Trans."},{"key":"B27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10072-013-1558-7","article-title":"The Rao\u2019s brief repeatable battery version B: normative values with age, education and gender corrections in an Italian population.","volume":"35","author":"Goretti","year":"2014","journal-title":"Neurol. Sci."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"B29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature11356","article-title":"Autistic-like behavior in Scn1a+\/- mice and rescue by enhanced GABA-mediated neurotransmission.","volume":"489","author":"Han","year":"2012","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1017\/S0714980815000082","article-title":"Associations between benzodiazepine use and neuropsychological test scores in older adults.","volume":"34","author":"Helmes","year":"2015","journal-title":"Can. J. Aging"},{"key":"B31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/bcp.12023","article-title":"Benzodiazepine dependence and its treatment with low dose flumazenil.","volume":"77","author":"Hood","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pscychresns.2017.05.009","article-title":"Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: the Northern Finland Birth Cohort 1966 study.","volume":"266","author":"Huhtaniska","year":"2017","journal-title":"Psychiatr. Res. Neuroimag."},{"key":"B33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000454881","article-title":"Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis.","volume":"47","author":"Islam","year":"2016","journal-title":"Neuroepidemiology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jsat.2011.12.011","article-title":"Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification.","volume":"43","author":"Kawasaki","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1097\/CCM.0000000000003300","article-title":"Benzodiazepine use and neuropsychiatric outcomes in the ICU: a systematic review.","volume":"46","author":"Kok","year":"2018","journal-title":"Crit. Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1007\/s00702-014-1282-3","article-title":"Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning.","volume":"122","author":"Krysta","year":"2015","journal-title":"J. Neural Trans."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142057","article-title":"High-dose benzodiazepine dependence: a qualitative study of patients\u2019 perceptions on initiation, reasons for use, and obtainment.","volume":"10","author":"Liebrenz","year":"2015","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugalcdep.2014.06.020","article-title":"Quality of life in a cohort of high-dose benzodiazepine dependent patients.","volume":"142","author":"Lugoboni","year":"2014","journal-title":"Drug Alcoh. Depend."},{"key":"B39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0197-4580(94)90146-5","article-title":"Chronic administration of flumazenil increases life span and protects rats from age-related loss of cognitive functions: a benzodiazepine\/GABAergic hypothesis of brain aging.","volume":"15","author":"Marczynski","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1523\/JNEUROSCI.4209-09.2010","article-title":"Alpha5 GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory.","volume":"30","author":"Martin","year":"2010","journal-title":"J. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2014.10.008","article-title":"The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in down syndrome and social interaction in autism.","volume":"72","author":"M\u00f6hler","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10072-012-1130-x","article-title":"Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population.","volume":"34","author":"Monaco","year":"2013","journal-title":"Neurol. Sci."},{"journal-title":"Esame neuropsicologico Breve 2, ENB-2.","year":"2011","author":"Mondini","key":"B43"},{"key":"B44","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4088\/jcp.v63n0912","article-title":"Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom.","volume":"63","author":"Ohayon","year":"2002","journal-title":"J. Clin. Psychiatry"},{"journal-title":"Manuale Dell\u2019adattamento Italiano Dello STAI Forma Y. Organizzazioni Speciali.","year":"1989","author":"Pedrabissi","key":"B45"},{"key":"B46","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/YIC.0b013e328105e0f2","article-title":"Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies.","volume":"22","author":"Petitjean","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2146\/ajhp160381","article-title":"Benzodiazepine use and cognitive decline in the elderly.","volume":"75","author":"Picton","year":"2018","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00228-013-1613-6","article-title":"Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.","volume":"70","author":"Puustinen","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","article-title":"Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults.","volume":"73","author":"Risacher","year":"2016","journal-title":"JAMA Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/bf02245054","article-title":"Sedative, memory, and performance effects of hypnotics.","volume":"116","author":"Roehrs","year":"1994","journal-title":"Psychopharmacology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.conb.2012.05.002","article-title":"Cognitive and pharmacological insights from the Ts65Dn mouse model of down syndrome.","volume":"22","author":"Ruparelia","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"B52","article-title":"The Italian versions of the beck anxiety inventory and the beck depression inventory-II: psychometric properties and discriminant power","author":"Sica","year":"2007","journal-title":"Leading-Edge Psychological Tests And Testing Research"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1056\/NEJMra1611832","article-title":"Treatment of benzodiazepine dependence.","volume":"376","author":"Soyka","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2014.01.008","article-title":"Impulsivity as a vulnerability factor for poor addiction treatment outcomes: a review of neurocognitive findings among individuals with substance use disorders.","volume":"47","author":"Stevens","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"B55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00702-013-1078-x","article-title":"Biomarkers of cognitive dysfunction in traumatic brain injury.","volume":"121","author":"Sun","year":"2014","journal-title":"J. Neural. Trans."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1177\/0269881117714050","article-title":"Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence.","volume":"31","author":"Tamburin","year":"","journal-title":"J. Psychopharmacol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph14010038","article-title":"Determinants of quality of life in high-dose benzodiazepine misusers.","volume":"14","author":"Tamburin","year":"","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B58","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction.","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0043-112755","article-title":"Influence of long-term benzodiazepine use on neurocognitive skills related to driving performance in patient populations: a review.","volume":"50","author":"van der Sluiszen","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S0033291704003897","article-title":"Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies.","volume":"35","author":"Verdoux","year":"2005","journal-title":"Psychol. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00228-019-02668-3","article-title":"Medication and medical diagnosis as risk factors for falls in older hospitalized patients.","volume":"75","author":"Wedmann","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/bf02245635","article-title":"Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.","volume":"121","author":"Wesensten","year":"1995","journal-title":"Psychopharmacology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1111\/j.1460-9568.2004.03642.x","article-title":"GABA receptors containing the \u03b15 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear.","volume":"20","author":"Yee","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/WAD.0000000000000099","article-title":"Benzodiazepine use and cognitive decline in elderly with normal cognition.","volume":"30","author":"Zhang","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B65","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/practneurol-2017-00-1743","article-title":"Neuropsychological testing.","volume":"18","author":"Zucchella","year":"","journal-title":"Pract. Neurol."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01058","article-title":"The multidisciplinary approach to alzheimer\u2019s disease and dementia. a narrative review of non-pharmacological treatment.","volume":"9","author":"Zucchella","year":"","journal-title":"Front. Neurol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00747\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T07:50:58Z","timestamp":1595317858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00747\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":66,"alternative-id":["10.3389\/fnins.2020.00747"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00747","relation":{},"ISSN":["1662-453X"],"issn-type":[{"type":"electronic","value":"1662-453X"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"article-number":"747"}}